Aurora Spine Stock Performance
| ASAPF Stock | USD 0.25 0.01 4.17% |
On a scale of 0 to 100, Aurora Spine holds a performance score of 4. The firm shows a Beta (market volatility) of 0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aurora Spine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aurora Spine is expected to be smaller as well. Please check Aurora Spine's treynor ratio and the relationship between the downside variance and day typical price , to make a quick decision on whether Aurora Spine's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Aurora Spine are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly abnormal basic indicators, Aurora Spine reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -720.6 K |
Aurora |
Aurora Spine Relative Risk vs. Return Landscape
If you would invest 22.00 in Aurora Spine on April 22, 2025 and sell it today you would earn a total of 2.00 from holding Aurora Spine or generate 9.09% return on investment over 90 days. Aurora Spine is currently producing 0.2418% returns and takes up 4.5514% volatility of returns over 90 trading days. Put another way, 40% of traded otc stocks are less volatile than Aurora, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Aurora Spine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aurora Spine's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Aurora Spine, and traders can use it to determine the average amount a Aurora Spine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0531
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ASAPF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Aurora Spine is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurora Spine by adding it to a well-diversified portfolio.
Aurora Spine Fundamentals Growth
Aurora OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Aurora Spine, and Aurora Spine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aurora OTC Stock performance.
| Return On Equity | -0.27 | |||
| Return On Asset | -0.0851 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 66.73 M | |||
| Price To Book | 4.22 X | |||
| Price To Sales | 1.70 X | |||
| Revenue | 10.54 M | |||
| EBITDA | (1.9 M) | |||
| Cash And Equivalents | 758.98 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.27 M | |||
| Debt To Equity | 0.58 % | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (2.13 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 10.56 M | |||
About Aurora Spine Performance
By analyzing Aurora Spine's fundamental ratios, stakeholders can gain valuable insights into Aurora Spine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aurora Spine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aurora Spine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada. Aurora Spine is traded on OTC Exchange in the United States.Things to note about Aurora Spine performance evaluation
Checking the ongoing alerts about Aurora Spine for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Aurora Spine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aurora Spine has some characteristics of a very speculative penny stock | |
| Aurora Spine had very high historical volatility over the last 90 days | |
| The company reported the revenue of 10.54 M. Net Loss for the year was (2.36 M) with profit before overhead, payroll, taxes, and interest of 4.83 M. | |
| Aurora Spine has accumulated about 758.98 K in cash with (2.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 18.0% of the company shares are held by company insiders |
- Analyzing Aurora Spine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aurora Spine's stock is overvalued or undervalued compared to its peers.
- Examining Aurora Spine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aurora Spine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aurora Spine's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Aurora Spine's otc stock. These opinions can provide insight into Aurora Spine's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aurora OTC Stock analysis
When running Aurora Spine's price analysis, check to measure Aurora Spine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurora Spine is operating at the current time. Most of Aurora Spine's value examination focuses on studying past and present price action to predict the probability of Aurora Spine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurora Spine's price. Additionally, you may evaluate how the addition of Aurora Spine to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |